Selank Peptide research-grade
Selank Peptide
$31.00 $85.00Price range: $31.00 through $85.00 Select options

Selank Peptide

Price range: $31.00 through $85.00

Research-grade Selank Peptide for laboratory investigation. For Research Use Only. Not for human use.

For Research Use Only — Not for Human Consumption
Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Checkout

Accepted Payment Methods

For Research Use Only. Not for human use.

Selank Peptide research-grade

Overview

Selank Peptide is supplied as a research-grade catalog material for controlled laboratory investigation.

Laboratories choose this item when protocols need clear identification, consistent labeling, and documentation suitable for reproducible experimental workflows.

Catalog packaging and research-use labeling help purchasing and bench teams keep procurement records aligned with the physical vial.

Research Context for Selank Peptide

Work involving Selank Peptide typically focuses on in vitro systems, assay development, and mechanistic model studies.

Teams confirm lot details before setup so conditions stay traceable across repeats and collaborative sites.

Published literature can inform starting ranges for related experimental designs. Each laboratory should still validate performance with its own instruments, plates, and detection chemistry.

Pilot runs are useful before committing larger plate sets, especially when detection chemistry or incubation windows are being optimized.

Documented Attributes

Key catalog attributes for this material include:

  • Research-grade material intended for laboratory investigation only
  • Catalog labeling aligned with research procurement channels
  • Suitable for method development and comparative assay workflows
  • Documentation packages available where provided for the listed lot

Laboratory Handling Notes

Receiving and Identity Checks

Before opening a vial of Selank Peptide, confirm the physical label against the purchase order and packing list.

Retain outer packaging until identity checks are complete, and report damaged seals to purchasing before experimental work continues.

Reconstitution and Aliquoting

Handle this material according to institutional SOPs for weighing, reconstitution, aliquoting, and storage.

Record lot identifiers in laboratory notebooks before reconstitution. Verify solvent compatibility and storage temperature against your validated process.

Prepare assay buffers and consumables before opening the vial to reduce hold time. Keep unused aliquots labeled with date, solvent, and concentration for later repeats.

Chain of Custody

Keep chain-of-custody notes with inventory checks when material moves between freezers or benches.

Use dedicated spatulas and clean balances to avoid cross-contamination between catalog items. Schedule thaw cycles intentionally rather than repeated freeze-thaw of the same aliquot.

Secondary containment trays reduce spill risk during multi-step reconstitution. Cold-chain interruptions should be noted even when the vial remains sealed.

Why Laboratories Source Selank Peptide

Procurement and research teams often select this catalog item because it supports:

  • Clear research-use labeling for compliance-aligned purchasing
  • Consistent product identification across multi-lot studies
  • Fit for reference, screening, and mechanistic laboratory models
  • Straightforward catalog support for planning and documentation

Study Planning and Quality Documentation

Before starting experimental work with Selank Peptide, review any COA or quality files provided with the shipment.

Align your protocol with institutional research requirements and keep use within the labeled research context.

File catalog documentation with the study records at receipt. These steps help keep experiments comparable over time when using Selank Peptide in sequential study phases.

Method Development Tips

Method development often begins with small pilot plates before larger screening panels.

Document buffer lots, incubation times, and detection settings alongside the material lot number.

If results diverge from historical baselines, re-check reconstitution volume and storage history first. Shared equipment logs help explain variance when multiple operators run the same protocol.

Inventory and Training

Update digital inventory immediately after opening a new lot of Selank Peptide.

Training new staff on labeling conventions reduces mix-ups across similar catalog SKUs. When transferring methods between sites, share both the written SOP and the lot metadata package.

Dispose of residual solutions according to institutional chemical hygiene rules. Do not repurpose research materials for any non-laboratory application.

Periodic inventory reconciliation keeps expired or depleted lots from entering active workflows. For related catalog options, browse adjacent research categories on this site after confirming your assay needs.

For Research Use Only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease.

Peptide Research

For Research Use Only. Not for human use.

PubMed (NIH/NLM) records related to this compound for laboratory literature review. Inclusion does not imply suitability for any use beyond controlled research. Each note below is a research-framed summary using compliance-safe wording.

Showing 59 PubMed records. Displaying 10 per page.

  1. Panikratova YR et al. (2020). Functional Connectomic Approach to Studying Selank and Semax Effects [PMID: 32342318]

    Laboratory literature summary: Functional Connectomic Approach to Studying Selank and Semax Effects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  2. Konstantinopolsky MA et al. (2022). Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal… [PMID: 36322304]

    Laboratory literature summary: Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  3. Fomenko EV et al. (2019). Effect of Selank on Morphological Parameters of Rat Liver in Chronic Foot-Shock Stress [PMID: 31243679]

    Laboratory literature summary: Effect of Selank on Morphological Parameters of Rat Liver in Chronic Foot-Shock Stress. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  4. Leonidovna YA et al. (2021). The Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress [PMID: 32621722]

    Laboratory literature summary: The Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  5. Volkova A et al. (2016). Selank Administration Affects the Expression of Some Genes Involved in GABAergic… [PMID: 26924987]

    Laboratory literature summary: Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  6. Filatova E et al. (2017). GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic… [PMID: 28293190]

    Laboratory literature summary: GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  7. Kolomin T et al. (2014). The temporary dynamics of inflammation-related genes expression under tuftsin analog… [PMID: 24291245]

    Laboratory literature summary: The temporary dynamics of inflammation-related genes expression under tuftsin analog Selank action. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  8. Kasian A et al. (2017). Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable… [PMID: 28280289]

    Laboratory literature summary: Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  9. Vyunova TV et al. (2018). Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological… [PMID: 30255741]

    Laboratory literature summary: Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  10. Kolik LG et al. (2019). Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory… [PMID: 31625062]

    Laboratory literature summary: Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  11. Fomenko EV et al. (2017). Effect of Selank on Functional State of Rat Hepatocytes under Conditions of Restraint… [PMID: 28853100]

    Laboratory literature summary: Effect of Selank on Functional State of Rat Hepatocytes under Conditions of Restraint Stress. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  12. Povarov IS et al. (2017). Effect of Selank on Spontaneous Synaptic Activity of Rat Hippocampal CA1 Neurons [PMID: 28361410]

    Laboratory literature summary: Effect of Selank on Spontaneous Synaptic Activity of Rat Hippocampal CA1 Neurons. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  13. Medvedev VE et al. (2015). [Optimization of the investigation of anxiety disorders with selank] [PMID: 26356395]

    Laboratory literature summary: [Optimization of the investigation of anxiety disorders with selank]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  14. Mukhina AY et al. (2019). State of Colon Microbiota in Rats during Chronic Restraint Stress and Selank investigation [PMID: 31236882]

    Laboratory literature summary: State of Colon Microbiota in Rats during Chronic Restraint Stress and Selank investigation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  15. Mukhina AY et al. (2020). Morphological Changes in the Large Intestine of Rats Subjected to Chronic Restraint… [PMID: 32651826]

    Laboratory literature summary: Morphological Changes in the Large Intestine of Rats Subjected to Chronic Restraint Stress and studied with Selank. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  16. Kozlovskii II et al. (2003). The optimizing action of the synthetic peptide Selank on a conditioned active… [PMID: 14552529]

    Laboratory literature summary: The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  17. Kolomin T et al. (2011). Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank [PMID: 21609736]

    Laboratory literature summary: Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  18. Sarkisova KIu et al. (2008). Laboratory research record on Selank [PMID: 18661785]

    PubMed laboratory record discussing Selank in a research context. Review the full methods and limitations on PubMed; research use only.

  19. Vasil'eva EV et al. (2016). [COMPARISON OF PHARMACOLOGICAL EFFECTS OF HEPTAPEPTIDE SELANK AFTER INTRANASAL AND… [PMID: 29787664]

    Laboratory literature summary: [COMPARISON OF PHARMACOLOGICAL EFFECTS OF HEPTAPEPTIDE SELANK AFTER INTRANASAL AND INTRAPERITONEAL ADMINISTRATION TO BALB/c AND C57BL/6…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  20. Kolik LG et al. (2016). Selank Inhibits Ethanol-Induced Hyperlocomotion and Manifestation of Behavioral… [PMID: 27878720]

    Laboratory literature summary: Selank Inhibits Ethanol-Induced Hyperlocomotion and Manifestation of Behavioral Sensitization in DBA/2 Mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  21. Zozulya AA et al. (2001). The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible… [PMID: 11550013]

    Laboratory literature summary: The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  22. Semenova TP et al. (2010). [Experimental optimization of learning and memory processes by selank] [PMID: 20919548]

    Laboratory literature summary: [Experimental optimization of learning and memory processes by selank]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  23. Semenova TP et al. (2005). Seasonal effects of Selank on the behavior of hibernating animals [PMID: 16848230]

    Laboratory literature summary: Seasonal effects of Selank on the behavior of hibernating animals. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  24. Pavlov TS et al. (2005). [Effect of new synthetic anxiolytic selank on gastric wall blood flow and mesenteryc… [PMID: 15835541]

    Laboratory literature summary: [Effect of new synthetic anxiolytic selank on gastric wall blood flow and mesenteryc lymphatic vessels contractility in anesthetized rats]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  25. Semenova TP et al. (2009). [Comparison of the effects of selank and tuftsin on the metabolism of serotonin in the… [PMID: 19803361]

    Laboratory literature summary: [Comparison of the effects of selank and tuftsin on the metabolism of serotonin in the brain of rats pretreated with PCPA]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  26. Medvedev VE et al. (2014). [A comparison of the anxiolytic effect and tolerability of selank and phenazepam in… [PMID: 25176261]

    Laboratory literature summary: [A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the investigation of anxiety disorders]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  27. Uchakina ON et al. (2008). [Immunomodulatory effects of selank in research subjects with anxiety-asthenic disorders] [PMID: 18577961]

    Laboratory literature summary: [Immunomodulatory effects of selank in research subjects with anxiety-asthenic disorders]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  28. Meshavkin VK et al. (2006). Naloxone-blocked depriming effect of anxiolytic selank on apomorphine-induced… [PMID: 17415472]

    Laboratory literature summary: Naloxone-blocked depriming effect of anxiolytic selank on apomorphine-induced behavioral manifestations of hyperfunction of dopamine system. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  29. Mjasoedov NF et al. (2014). The influence of Selank on the parameters of the hemostasis system, lipid profile, and… [PMID: 25371249]

    Laboratory literature summary: The influence of Selank on the parameters of the hemostasis system, lipid profile, and blood sugar level in the course of experimental…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  30. Liapina LA et al. (2006). [Comparison of anticoagulant effects of regulatory proline-containing oligopeptides.… [PMID: 16634437]

    Laboratory literature summary: [Comparison of anticoagulant effects of regulatory proline-containing oligopeptides. Specificity of glyprolines, semax, and selank and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  31. Slominsky PA et al. (2017). Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like… [PMID: 28702721]

    Laboratory literature summary: Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like neurodegeneration research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  32. Semenova TP et al. (2007). Effect of selank on cognitive processes after damage inflicted to the cerebral… [PMID: 18683497]

    Laboratory literature summary: Effect of selank on cognitive processes after damage inflicted to the cerebral catecholamine system during early ontogeny. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  33. Kolomin TA et al. (2013). [Transcriptome alteration in hippocampus under the investigation of tuftsin analog Selank] [PMID: 24450168]

    Laboratory literature summary: [Transcriptome alteration in hippocampus under the investigation of tuftsin analog Selank]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  34. Pavlov TS et al. (2004). A new property of the synthetic anxiolytic Selank and its derivatives [PMID: 15508574]

    Laboratory literature summary: A new property of the synthetic anxiolytic Selank and its derivatives. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  35. Pavlov TS et al. (2007). Selank and its metabolites maintain homeostasis in the gastric mucosa [PMID: 18019011]

    Laboratory literature summary: Selank and its metabolites maintain homeostasis in the gastric mucosa. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  36. Andreeva LA et al. (2010). Antiviral properties of structural fragments of the peptide Selank [PMID: 20506839]

    Laboratory literature summary: Antiviral properties of structural fragments of the peptide Selank. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  37. Kozlovskiĭ II et al. (2002). [Optimizing action of synthetic peptide Selank on active avoidance conditioning test… [PMID: 12449836]

    Laboratory literature summary: [Optimizing action of synthetic peptide Selank on active avoidance conditioning test in rats]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  38. Narkevich VB et al. (2008). [Effects of heptapeptide selank on the content of monoamines and their metabolites in… [PMID: 19093364]

    Laboratory literature summary: [Effects of heptapeptide selank on the content of monoamines and their metabolites in the brain of BALB/C and C57Bl/6 mice: a…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  39. Author et al. (2008). [Compensatory and antiamnestic effects of heptapeptide Selank in monkeys] [PMID: 18727417]

    Laboratory literature summary: [Compensatory and antiamnestic effects of heptapeptide Selank in monkeys]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  40. Zozulia AA et al. (2008). [observed endpoints and possible mechanisms of action of a new peptide anxiolytic… [PMID: 18454096]

    Laboratory literature summary: [observed endpoints and possible mechanisms of action of a new peptide anxiolytic selank in the research protocol of generalized anxiety…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  41. Kolik LG et al. (2014). Observed endpoints of peptide anxiolytic selank during modeling of withdrawal syndrome… [PMID: 24913576]

    Laboratory literature summary: observed endpoints of peptide anxiolytic selank during modeling of withdrawal syndrome in rats with stable alcoholic motivation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  42. Kolomin TA et al. (2011). [Changes in expression of the genes for chemokines, cytokines, and their receptors in… [PMID: 21786679]

    Laboratory literature summary: [Changes in expression of the genes for chemokines, cytokines, and their receptors in response to selank and its fragments]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  43. Kost NV et al. (2001). [Semax and selank inhibit the enkephalin-degrading enzymes from research subjects serum]] [PMID: 11443939]

    Laboratory literature summary: [Semax and selank inhibit the enkephalin-degrading enzymes from research subjects serum]]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  44. Ershov FI et al. (2009). [Antiviral activity of immunomodulator Selank in experimental influenza infection] [PMID: 19882898]

    Laboratory literature summary: [Antiviral activity of immunomodulator Selank in experimental influenza infection]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  45. Kozlovskiĭ II et al. (2008). [Compensatory effect of selank on the mnestic functions disturbed by neurotoxic damage… [PMID: 18488898]

    Laboratory literature summary: [Compensatory effect of selank on the mnestic functions disturbed by neurotoxic damage of the noradrenergic system of the rat brain]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  46. Semenova TP et al. (2008). Use of Selank to correct measures of integrative brain activity and biogenic amine… [PMID: 18197389]

    Laboratory literature summary: Use of Selank to correct measures of integrative brain activity and biogenic amine levels in adult rats resulting from antenatal hypoxia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  47. Kozlovskiĭ II et al. (2013). [Protective effect of selank on the model of mnestic function violation induced by… [PMID: 24605419]

    Laboratory literature summary: [Protective effect of selank on the model of mnestic function violation induced by pharmacological blockade of protein synthesis]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  48. Doyno CR et al. (2021). Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on… [PMID: 34396551]

    Laboratory literature summary: Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  49. Inozemtseva LS et al. (2008). Intranasal administration of the peptide Selank regulates BDNF expression in the rat… [PMID: 18841804]

    Laboratory literature summary: Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  50. Gan'shina TS et al. (2005). [Effects of the new peptide anxiolytic drug selank on the cardiovascular system… [PMID: 16193654]

    Laboratory literature summary: [Effects of the new peptide anxiolytic drug selank on the cardiovascular system functioning and respiration in cats]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  51. Kolomin TA et al. (2010). Transcriptomic response of rat hippocampus and spleen cells to single and chronic… [PMID: 20380151]

    Laboratory literature summary: Transcriptomic response of rat hippocampus and spleen cells to single and chronic administration of the peptide selank. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  52. Semenova TP et al. (2006). [Selank-induced normalizing effects on the integrative brain activity and biogenic… [PMID: 17385425]

    Laboratory literature summary: [Selank-induced normalizing effects on the integrative brain activity and biogenic amine level disorders due to antenatal hypoxia]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  53. Kozlovskaya MM et al. (2003). Selank and short peptides of the tuftsin family in the regulation of adaptive behavior… [PMID: 14969422]

    Laboratory literature summary: Selank and short peptides of the tuftsin family in the regulation of adaptive behavior in stress. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  54. Kozlovskiĭ II et al. (2012). [The role of opioid system in peculiarities of anti-anxiety effect of peptide… [PMID: 22550852]

    Laboratory literature summary: [The role of opioid system in peculiarities of anti-anxiety effect of peptide anxiolytic selank]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  55. Solov'ev VB et al. (2012). [Effect of selank on the main carboxypeptidases in the rat nervous tissue] [PMID: 22827026]

    Laboratory literature summary: [Effect of selank on the main carboxypeptidases in the rat nervous tissue]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  56. Sokolov OY et al. (2002). Effects of Selank on behavioral reactions and activities of plasma… [PMID: 12432865]

    Laboratory literature summary: Effects of Selank on behavioral reactions and activities of plasma enkephalin-degrading enzymes in mice with different phenotypes of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  57. Kozlovskaia MM et al. (2002). [Selank and short peptides of Taftsin derivatives in regulation of adaptive behavior… [PMID: 12154572]

    Laboratory literature summary: [Selank and short peptides of Taftsin derivatives in regulation of adaptive behavior of animals in stress]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  58. Zolotarev IuA et al. (2004). [Leu-enkephalin homogeneously labeled with tritium in studying the Selank inhibiting… [PMID: 15344652]

    Laboratory literature summary: [Leu-enkephalin homogeneously labeled with tritium in studying the Selank inhibiting effect on the enkephalin-degrading enzymes of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  59. Skvortsova VI et al. (2009). Laboratory research record on Selank [PMID: 20873405]

    PubMed laboratory record discussing Selank in a research context. Review the full methods and limitations on PubMed; research use only.

Browse the full PubMed index: PubMed search.

Additional information

Weight .125 lbs
Dimensions 8 × 7 × .5 in
Size: No selection

5mg, 10mg

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.

Frequently Asked Questions

What is Selank peptide?

Selank is a synthetic peptide derived from the naturally occurring tuftsin molecule. It is commonly studied in research settings for its potential effects on mood regulation, cognitive function, and anxiety-related pathways.

What is Selank used for in research?

Selank is widely used in laboratory research to investigate its potential nootropic, anxiolytic, and neuroprotective properties. It is not approved for human use.

Is Selank Peptide approved or intended for human use?

No. Selank sold on this website is strictly intended for research purposes only and is not approved by the FDA for human use.

What form does Selank come in?

Selank is supplied as a lyophilized (freeze-dried) powder

How should Selank be stored?

Selank should be stored in a cool, dry place. It is recommended to store the solution under refrigeration to maintain stability.

What are the available vial sizes or quantities?

Selank is available in multiple vial sizes (e.g., 5000 IU, 10,000 IU).

Is Selank Peptide sold as a prescription product?

No prescription is required for purchase; however, the product is strictly designated for research use only and must not be used for human consumption.

Is Selank Peptide FDA-approved for medical or clinical use?

No. Selank is not approved by the U.S. Food and Drug Administration (FDA) for any medical or investigational use.

How is Selank shipped?

Orders are processed and shipped securely, with discreet packaging to ensure product integrity during transit. For more info, visit: https://www.nationwidepeptides.com/shipping-and-payments/

How can I verify Selank purity and quality?

Product quality is supported through third-party testing and Certificates of Analysis (COA), which confirm purity and batch consistency. For more info, visit: https://www.nationwidepeptides.com/coa/